U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07295392) titled 'Is There Any Prognostic Value of Serum Uromodulin in Sepsis Induced AKI , as a Tool Helping us to Predict the Clinical Outcomes in Adult Patient With Sepsis Induced AKI.' on Dec. 08.

Brief Summary: To determine whether baseline (day 0; day of diagnosis),day 7 and on discharge serum uromodulin levels help predict clinical outcomes in adult patients with sepsis induced AKI.

Study Start Date: March 10, 2026

Study Type: OBSERVATIONAL

Condition: Sepsis Induced Acute Kidney Injury

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Shaymaa Ibrahim Mohammed Hassan, Assiut Un...